# Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia

> **NCT02137993** · PHASE4 · COMPLETED · sponsor: **HK inno.N Corporation** · enrollment: 64 (actual)

## Conditions studied

- Schizophrenia
- Schizophreniform Disorder
- Schizoaffective Disorder

## Interventions

- **DRUG:** A-prexa
- **DRUG:** Zyprexa

## Key facts

- **NCT ID:** NCT02137993
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2014-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02137993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02137993, "Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02137993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*